Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Ducrotté P[au]:

Clinical trial: Lactobacillus plantarum 299v (DSM 9843) improves symptoms of irritable bowel syndrome. Ducrotté P et al. World J Gastroenterol. (2012)

Long term outcome of patients with low level of cryoglobulin (<0.05g/L). Eble V et al. Autoimmun Rev. (2016)

[Constipation and cancer: Current strategies]. Gervais C et al. Bull Cancer. (2016)

Search results

Items: 1 to 50 of 287

1.

Is abnormal 25 g fructose breath test a predictor of symptomatic response to a low fructose diet in irritable bowel syndrome?

Melchior C, Desprez C, Houivet E, Debeir LA, Bril L, Maccarone M, Grout E, Ducrotté P, Gourcerol G, Leroi AM.

Clin Nutr. 2019 May 8. pii: S0261-5614(19)30207-9. doi: 10.1016/j.clnu.2019.04.031. [Epub ahead of print]

PMID:
31113646
2.

Colonic Proteome Signature in Immunoproteasome-Deficient Stressed Mice and Its Relevance for Irritable Bowel Syndrome.

Goichon A, Bahlouli W, Ghouzali I, Chan P, Vaudry D, Déchelotte P, Ducrotté P, Coëffier M.

J Proteome Res. 2019 Jan 4;18(1):478-492. doi: 10.1021/acs.jproteome.8b00793. Epub 2018 Nov 26.

PMID:
30475625
3.

Efficacy of Gastric Electrical Stimulation for Gastroparesis: US/European Comparison.

Burlen J, Runnels M, Mehta M, Andersson S, Ducrotte P, Gourcerol G, Lindberg G, Fullarton G, Abrahamsson H, Al-Juburi A, Lahr C, Rashed H, Abell T.

Gastroenterology Res. 2018 Oct;11(5):349-354. doi: 10.14740/gr1061w. Epub 2018 Oct 1.

4.

Peroral endoscopic pyloromyotomy is efficacious and safe for refractory gastroparesis: prospective trial with assessment of pyloric function.

Jacques J, Pagnon L, Hure F, Legros R, Crepin S, Fauchais AL, Palat S, Ducrotté P, Marin B, Fontaine S, Boubaddi NE, Clement MP, Sautereau D, Loustaud-Ratti V, Gourcerol G, Monteil J.

Endoscopy. 2019 Jan;51(1):40-49. doi: 10.1055/a-0628-6639. Epub 2018 Jun 12.

PMID:
29895073
5.

Correction: Octreotide modulates the expression of somatostatin receptor subtypes in inflamed rat jejunum induced by Cryptosporidium parvum.

Bai J, Liu X, Le Goff L, Gargala G, François A, Ballet JJ, Ducrotte P, Favennec L, Towledahong L.

PLoS One. 2018 May 24;13(5):e0198377. doi: 10.1371/journal.pone.0198377. eCollection 2018.

6.

Octreotide modulates the expression of somatostatin receptor subtypes in inflamed rat jejunum induced by Cryptosporidium parvum.

Bai J, Liu X, Le Goff L, Gargala G, François A, Ballet JJ, Ducrotte P, Favennec L, Towledahong L.

PLoS One. 2018 Mar 9;13(3):e0194058. doi: 10.1371/journal.pone.0194058. eCollection 2018. Erratum in: PLoS One. 2018 May 24;13(5):e0198377.

7.

Are characteristics of abdominal pain helpful to identify patients with visceral hypersensitivity in irritable bowel syndrome? Results of a prospective study.

Melchior C, Bril L, Leroi AM, Gourcerol G, Ducrotté P.

Neurogastroenterol Motil. 2018 Jun;30(6):e13290. doi: 10.1111/nmo.13290. Epub 2018 Jan 18.

PMID:
29345401
8.

The diagnostic value of the functional lumen imaging probe versus high-resolution anorectal manometry in patients with fecal incontinence.

Leroi AM, Melchior C, Charpentier C, Bridoux V, Savoye-Collet C, Houivet E, Ducrotté P, Gourcerol G.

Neurogastroenterol Motil. 2018 Jun;30(6):e13291. doi: 10.1111/nmo.13291. Epub 2018 Jan 18.

PMID:
29345097
9.

[Management of functional bowel disorders].

Ducrotté P, Melchior C.

Rev Prat. 2018 Jan;68(1):18-24. French.

PMID:
30840380
10.

Dramatic Increase in Incidence of Ulcerative Colitis and Crohn's Disease (1988-2011): A Population-Based Study of French Adolescents.

Ghione S, Sarter H, Fumery M, Armengol-Debeir L, Savoye G, Ley D, Spyckerelle C, Pariente B, Peyrin-Biroulet L, Turck D, Gower-Rousseau C, Andre JM, Antonietti M, Aouakli A, Armand A, Aroichane I, Assi F, Aubet JP, Auxenfants E, Ayafi-Ramelot F, Bankovski D, Barbry B, Bardoux N, Baron P, Baudet A, Bazin B, Bebahani A, Becqwort JP, Benet V, Benali H, Benguigui C, Soussan BE, Bental A, Berkelmans I, Bernet J, Bernou K, Bernou-Dron C, Bertot P, Bertiaux-Vandaële N, Bertrand V, Billoud E, Biron N, Bismuth B, Bleuet M, Blondel F, Blondin V, Bohon P, Boniface E, Bonnière P, Bonvarlet E, Bonvarlet P, Boruchowicz A, Bostvironnois R, Boualit M, Bouche B, Boudaillez C, Bourgeaux C, Bourgeois M, Bourguet A, Bourienne A, Branche J, Bray G, Brazier F, Breban P, Brihier H, Brung-Lefebvre V, Bulois P, Burgiere P, Butel J, Canva JY, Canva-Delcambre V, Capron JP, Cardot F, Carpentier P, Cartier E, Cassar JF, Cassagnou M, Castex JF, Catala P, Cattan S, Catteau S, Caujolle B, Cayron G, Chandelier C, Chantre M, Charles J, Charneau T, Chavance-Thelu M, Chirita D, Choteau A, Claerbout JF, Clergue PY, Coevoet H, Cohen G, Collet R, Colombel JF, Coopman S, Corvisart J, Cortot A, Couttenier F, Crinquette JF, Crombe V, Dadamessi I, Dapvril V, Davion T, Dautreme S, Debas J, Degrave N, Dehont F, Delatre C, Delcenserie R, Delette O, Delgrange T, Delhoustal L, Delmotte JS, Demmane S, Deregnaucourt G, Descombes P, Desechalliers JP, Desmet P, Desreumaux P, Desseaux G, Desurmont P, Devienne A, Devouge E, Devred M, Devroux A, Dewailly A, Dharancy S, Di Fiore A, Djeddi D, Djedir R, Dreher-Duwat ML, Dubois R, Dubuque C, Ducatillon P, Duclay J, Ducrocq B, Ducrot F, Ducrotte P, Dufilho A, Duhamel C, Dujardin D, Dumant-Forest C, Dupas JL, Dupont F, Duranton Y, Duriez A, El Achkar K, El Farisi M, Elie C, Elie-Legrand MC, Elkhaki A, Eoche M, Evrard D, Evrard JP, Fatome A, Filoche B, Finet L, Flahaut M, Flamme C, Foissey D, Fournier P, Foutrein-Comes MC, Foutrein P, Fremond D, Frere T, Fumery M, Gallet P, Gamblin C, Ganga-Zandzou PS, Gérard R, Geslin G, Gheyssens Y, Ghossini N, Ghrib S, Gilbert T, Gillet B, Godard D, Godard P, Godchaux JM, Godchaux R, Goegebeur G, Goria O, Gottrand F, Gower P, Grandmaison B, Groux M, Guedon C, Guillard JF, Guillem L, Guillemot F, Guimber D, Haddouche B, Hakim S, Hanon D, Hautefeuille V, Heckestweiller P, Hecquet G, Hedde JP, Hellal H, Henneresse PE, Heyman B, Heraud M, Herve S, Hochain P, Houssin-Bailly L, Houcke P, Huguenin B, Iobagiu S, Ivanovic A, Iwanicki-Caron I, Janicki E, Jarry M, Jeu J, Joly JP, Jonas C, Katherin F, Kerleveo A, Khachfe A, Kiriakos A, Kiriakos J, Klein O, Kohut M, Kornhauser R, Koutsomanis D, Laberenne JE, Laffineur G, Lagarde M, Lannoy P, Lapchin J, Lapprand M, Laude D, Leblanc R, Lecieux P, Leclerc N, Le Couteulx C, Ledent J, Lefebvre J, Lefiliatre P, Legrand C, Le Grix A, Lelong P, Leluyer B, Lenaerts C, Lepileur L, Leplat A, Lepoutre-Dujardin E, Leroi H, Leroy MY, Lesage JP, Lesage X, Lesage J, Lescanne-Darchis I, Lescut J, Lescut D, Leurent B, Levy P, Lhermie M, Lion A, Lisambert B, Loire F, Louf S, Louvet A, Luciani M, Lucidarme D, Lugand J, Macaigne O, Maetz D, Maillard D, Mancheron H, Manolache O, Marks-Brunel AB, Marti R, Martin F, Martin G, Marzloff E, Mathurin P, Mauillon J, Maunoury V, Maupas JL, Mesnard B, Metayer P, Methari L, Meurisse B, Meurisse F, Michaud L, Mirmaran X, Modaine P, Monthe A, Morel L, Mortier PE, Moulin E, Mouterde O, Mudry J, Nachury M, Khac NE, Notteghem B, Ollevier V, Ostyn A, Ouraghi A, Ouvry D, Paillot B, Panien-Claudot N, Paoletti C, Papazian A, Parent B, Pariente B, Paris JC, Patrier P, Paupart L, Pauwels B, Pauwels M, Petit R, Piat M, Piotte S, Plane C, Plouvier B, Pollet E, Pommelet P, Pop D, Pordes C, Pouchain G, Prades P, Prevost A, Prevost JC, Quesnel B, Queuniet AM, Quinton JF, Rabache A, Rabelle P, Raclot G, Ratajczyk S, Rault D, Razemon V, Reix N, Revillon M, Richez C, Robinson P, Rodriguez J, Roger J, Roux JM, Rudelli A, Saber A, Savoye G, Schlosseberg P, Segrestin M, Seguy D, Serin M, Seryer A, Sevenet F, Shekh N, Silvie J, Simon V, Spyckerelle C, Talbodec N, Techy A, Thelu JL, Thevenin A, Thiebault H, Thomas J, Thorel JM, Tielman G, Tode M, Toisin J, Tonnel J, Touchais JY, Touze Y, Tranvouez JL, Triplet C, Turck D, Uhlen S, Vaillant E, Valmage C, Vanco D, Vandamme H, Vanderbecq E, Eecken VE, Vandermolen P, Vandevenne P, Vandeville L, Vandewalle A, Vandewalle C, Vaneslander P, Vanhoove JP, Vanrenterghem A, Varlet P, Vasies I, Verbiese G, Vernier-Massouille G, Vermelle P, Verne C, Vezilier-Cocq P, Vigneron B, Vincendet M, Viot J, Voiment YM, Wacrenier A, Waeghemaecker L, Wallez JY, Wantiez M, Wartel F, Weber J, Willocquet JL, Wizla N, Wolschies E, Zalar A, Zaouri B, Zellweger A, Ziade C; Epimad Group.

Am J Gastroenterol. 2018 Feb;113(2):265-272. doi: 10.1038/ajg.2017.228. Epub 2017 Aug 15.

PMID:
28809388
11.

Gastrointestinal Peptides During Chronic Gastric Electrical Stimulation in Patients With Intractable Vomiting.

Meleine M, Melchior C, Prinz P, Penfornis A, Coffin B, Stengel A, Ducrotté P, Gourcerol G.

Neuromodulation. 2017 Dec;20(8):774-782. doi: 10.1111/ner.12645. Epub 2017 Aug 10.

PMID:
28795473
12.

Efficacy of antibiotherapy for treating flatus incontinence associated with small intestinal bacterial overgrowth: A pilot randomized trial.

Melchior C, Gourcerol G, Bridoux V, Ducrotté P, Quinton JF, Leroi AM.

PLoS One. 2017 Aug 1;12(8):e0180835. doi: 10.1371/journal.pone.0180835. eCollection 2017.

13.

Prevalence and clinical features of opioid-induced constipation in the general population: A French study of 15,000 individuals.

Ducrotté P, Milce J, Soufflet C, Fabry C.

United European Gastroenterol J. 2017 Jun;5(4):588-600. doi: 10.1177/2050640616659967. Epub 2016 Jul 7.

14.

Tolerance and Long-Term Efficacy of Polyethylene Glycol 4000 (Forlax®) Compared to Lactulose in Elderly Patients with Chronic Constipation.

Chassagne P, Ducrotte P, Garnier P, Mathiex-Fortunet H.

J Nutr Health Aging. 2017;21(4):429-439. doi: 10.1007/s12603-016-0762-6.

PMID:
28346570
15.

Does calprotectin level identify a subgroup among patients suffering from irritable bowel syndrome? Results of a prospective study.

Melchior C, Aziz M, Aubry T, Gourcerol G, Quillard M, Zalar A, Coëffier M, Dechelotte P, Leroi AM, Ducrotté P.

United European Gastroenterol J. 2017 Mar;5(2):261-269. doi: 10.1177/2050640616650062. Epub 2016 Jun 23.

16.

An expert consensus definition of failure of a treatment to provide adequate relief (F-PAR) for chronic constipation - an international Delphi survey.

Tack J, Boardman H, Layer P, Schiefke I, Jayne D, Scarpignato C, Fox M, Frieling T, Ducrotte P, Hamdy S, Gill K, Ciriza de Los Rios C, Felt-Bersma R, De Looze D, Stanghellini V, Drewes AM, Simrén M, Pehl C, Hoheisel T, Leodolter A, Rey E, Dalrymple J, Emmanuel A.

Aliment Pharmacol Ther. 2017 Feb;45(3):434-442. doi: 10.1111/apt.13874. Epub 2016 Dec 1.

17.

Lactose malabsorption in systemic sclerosis.

Marie I, Leroi AM, Gourcerol G, Levesque H, Menard JF, Ducrotte P.

Aliment Pharmacol Ther. 2016 Nov;44(10):1123-1133. doi: 10.1111/apt.13810. Epub 2016 Sep 28.

18.

Targeting immunoproteasome and glutamine supplementation prevent intestinal hyperpermeability.

Ghouzali I, Lemaitre C, Bahlouli W, Azhar S, Bôle-Feysot C, Meleine M, Ducrotté P, Déchelotte P, Coëffier M.

Biochim Biophys Acta Gen Subj. 2017 Jan;1861(1 Pt A):3278-3288. doi: 10.1016/j.bbagen.2016.08.010. Epub 2016 Aug 17.

PMID:
27544233
19.

Proteasome inhibitors exacerbate interleukin-8 production induced by protease-activated receptor 2 in intestinal epithelial cells.

Ghouzali I, Azhar S, Bôle-Feysot C, Ducrotté P, Déchelotte P, Coëffier M.

Cytokine. 2016 Oct;86:41-46. doi: 10.1016/j.cyto.2016.07.014. Epub 2016 Jul 25.

PMID:
27455449
20.

[Constipation and cancer: Current strategies].

Gervais C, Ducrotté P, Piche T, Di Palma M, Jovenin N, Scotté F.

Bull Cancer. 2016 Sep;103(9):794-804. doi: 10.1016/j.bulcan.2016.05.010. Epub 2016 Jun 21. Review. French.

PMID:
27341746
21.

Long term outcome of patients with low level of cryoglobulin (<0.05g/L).

Eble V, Legallicier B, Joly P, Vittecoq O, Caron F, Tamion F, Ducrotte P, Levesque H, Menard JF, Jouen F, Guerrot D, Marie I.

Autoimmun Rev. 2016 May;15(5):440-6. doi: 10.1016/j.autrev.2016.01.012. Epub 2016 Jan 28. Review.

PMID:
26827906
22.

Do endoflip assessments of anal sphincter distensibility provide more information on patients with fecal incontinence than high-resolution anal manometry?

Gourcerol G, Granier S, Bridoux V, Menard JF, Ducrotté P, Leroi AM.

Neurogastroenterol Motil. 2016 Mar;28(3):399-409. doi: 10.1111/nmo.12740. Epub 2015 Dec 15.

PMID:
26670599
23.

Botulinum toxin: an endoscopic approach for treating fecal incontinence.

Gourcerol G, Bénard C, Melchior C, Touchais JY, Ducrotte P, Menard JF, Bridoux V, Leroi AM.

Endoscopy. 2016 May;48(5):484-8. doi: 10.1055/s-0034-1393242. Epub 2015 Oct 8.

PMID:
26448532
24.

Fructose Malabsorption in Systemic Sclerosis.

Marie I, Leroi AM, Gourcerol G, Levesque H, Ménard JF, Ducrotte P.

Medicine (Baltimore). 2015 Sep;94(39):e1601. doi: 10.1097/MD.0000000000001601.

25.

Glutamine Restores Tight Junction Protein Claudin-1 Expression in Colonic Mucosa of Patients With Diarrhea-Predominant Irritable Bowel Syndrome.

Bertrand J, Ghouzali I, Guérin C, Bôle-Feysot C, Gouteux M, Déchelotte P, Ducrotté P, Coëffier M.

JPEN J Parenter Enteral Nutr. 2016 Nov;40(8):1170-1176. Epub 2015 May 13.

PMID:
25972430
26.

Editorial: impaired fasting pyloric compliance in gastroparesis and the benefits of therapeutic pyloric dilatation--authors' reply.

Gourcerol G, Ducrotté P.

Aliment Pharmacol Ther. 2015 May;41(9):908. doi: 10.1111/apt.13157. No abstract available.

27.

Intestinal permeability in patients with diarrhea-predominant irritable bowel syndrome: is there a place for glutamine supplementation?

Coëffier M, Déchelotte P, Ducrotté P.

Gastroenterology. 2015 May;148(5):1079-80. doi: 10.1053/j.gastro.2015.02.057. Epub 2015 Mar 28. No abstract available.

PMID:
25824359
28.

Acute sacral nerve stimulation reduces visceral mechanosensitivity in Rat through spinal opioid pathway.

Langlois L, Meleine M, Ouelaa W, Caremel R, Bridoux V, Benard M, Dechelotte P, Ducrotte P, Grise P, Leroi AM, Gourcerol G.

Neurogastroenterol Motil. 2015 Jun;27(6):816-23. doi: 10.1111/nmo.12555. Epub 2015 Mar 25.

PMID:
25808214
29.

Fecal calprotectin in systemic sclerosis and review of the literature.

Marie I, Leroi AM, Menard JF, Levesque H, Quillard M, Ducrotte P.

Autoimmun Rev. 2015 Jun;14(6):547-54. doi: 10.1016/j.autrev.2015.01.018. Epub 2015 Feb 4. Review.

PMID:
25661980
30.

Impaired fasting pyloric compliance in gastroparesis and the therapeutic response to pyloric dilatation.

Gourcerol G, Tissier F, Melchior C, Touchais JY, Huet E, Prevost G, Leroi AM, Ducrotte P.

Aliment Pharmacol Ther. 2015 Feb;41(4):360-7. doi: 10.1111/apt.13053. Epub 2014 Dec 19.

31.

Diagnostic impact of routine colonoscopy following acute diverticulitis: A multicenter study in 808 patients and controls.

Lecleire S, Nahon S, Alatawi A, Antonietti M, Chaput U, Di-Fiore A, Alhameedi R, Marteau P, Ducrotté P, Dray X.

United European Gastroenterol J. 2014 Aug;2(4):301-6. doi: 10.1177/2050640614541765.

32.

Classification of adults suffering from typical gastroesophageal reflux disease symptoms: contribution of latent class analysis in a European observational study.

Bruley des Varannes S, Cestari R, Usova L, Triantafyllou K, Alvarez Sanchez A, Keim S, Bergmans P, Marelli S, Grahl E, Ducrotté P.

BMC Gastroenterol. 2014 Jun 26;14:112. doi: 10.1186/1471-230X-14-112.

33.

Efficacy of a CO2-releasing suppository in dyschezia: a double-blind, randomized, placebo-controlled clinical trial.

Tarrerias AL, Abramowitz L, Marty MM, Coulom P, Staumont G, Merlette C, Berger V, Savarieau B, Ducrotté P.

Dig Liver Dis. 2014 Aug;46(8):682-7. doi: 10.1016/j.dld.2014.04.005. Epub 2014 Jun 11.

PMID:
24928802
34.

Symptomatic fructose malabsorption in irritable bowel syndrome: A prospective study.

Melchior C, Gourcerol G, Déchelotte P, Leroi AM, Ducrotté P.

United European Gastroenterol J. 2014 Apr;2(2):131-7. doi: 10.1177/2050640614521124.

35.

Gastrointestinal mucosal abnormalities using videocapsule endoscopy in systemic sclerosis.

Marie I, Antonietti M, Houivet E, Hachulla E, Maunoury V, Bienvenu B, Viennot S, Smail A, Duhaut P, Dupas JL, Dominique S, Hatron PY, Levesque H, Benichou J, Ducrotté P.

Aliment Pharmacol Ther. 2014 Jul;40(2):189-99. doi: 10.1111/apt.12818. Epub 2014 Jun 2.

36.

A concomitant treatment by CO2-releasing suppositories improves the results of anorectal biofeedback training in patients with dyschezia: results of a randomized, double-blind, placebo-controlled trial.

Cotelle O, Cargill G, Marty MM, Bueno L, Cappelletti MC, Colangeli-Hagège H, Savarieau B, Ducrotté P.

Dis Colon Rectum. 2014 Jun;57(6):781-9. doi: 10.1097/DCR.0000000000000098.

PMID:
24807604
37.

Response to Barussaud et al.: the magnetic anal sphincter in faecal incontinence, is initial success sustained over time?

Bridoux V, Gourcerol G, Leroi AM, Ducrotte P, Michot F, Tuech JJ.

Colorectal Dis. 2014 Feb;16(2):145-6. doi: 10.1111/codi.12519. No abstract available.

PMID:
24330499
38.

Can multichannel intraluminal pH-impedance monitoring be limited to 3 hours? Comparison between ambulatory 24-hour and post-prandial 3-hour recording.

Gourcerol G, Verin E, Leroi AM, Ducrotté P.

Dis Esophagus. 2014 Nov-Dec;27(8):732-6. doi: 10.1111/dote.12161. Epub 2013 Nov 20.

PMID:
24251404
39.

On-demand treatment with alverine citrate/simeticone compared with standard treatments for irritable bowel syndrome: results of a randomised pragmatic study.

Ducrotte P, Grimaud JC, Dapoigny M, Personnic S, O'Mahony V, Andro-Delestrain MC.

Int J Clin Pract. 2014 Feb;68(2):245-54. doi: 10.1111/ijcp.12333. Epub 2013 Oct 21.

40.

Effect of transcranial magnetic stimulation on rectal sensitivity in irritable bowel syndrome: a randomized, placebo-controlled pilot study.

Melchior C, Gourcerol G, Chastan N, Verin E, Menard JF, Ducrotte P, Leroi AM.

Colorectal Dis. 2014 Mar;16(3):O104-11. doi: 10.1111/codi.12450.

PMID:
24119239
41.

Lack of correlation between morbid obesity and severe gastroesophageal reflux disease in candidates for bariatric surgery: results of a large prospective study.

Zalar A, Haddouche B, Antonietti M, Alhameedi R, Iwanicki-Caron I, Lecleire S, Ducrotté P.

Obes Surg. 2013 Nov;23(11):1939-41. doi: 10.1007/s11695-013-1064-2.

PMID:
24008624
42.

Response to Reshef et al.: Colectomy with ileorectal anastomosis has a worse 30-day outcome when performed for colonic inertia than for a neoplastic indication.

Bridoux V, Gourcerol G, Leroi AM, Ducrotte P, Michot F, Tuech JJ.

Colorectal Dis. 2013 Nov;15(11):1448-9. doi: 10.1111/codi.12373. No abstract available.

PMID:
23927647
43.

On-demand proton pump inhibitory treatment in overweight/obese patients with gastroesophageal reflux disease: are there pharmacodynamic arguments for using higher doses?

Bruley des Varannes S, Coudsy B, Waechter S, Delemos B, Xiang J, Lococo J, Ducrotté P.

Digestion. 2013;88(1):56-63. doi: 10.1159/000351389. Epub 2013 Jul 18.

PMID:
23880545
44.

Influence of gastric emptying on gastro-esophageal reflux: a combined pH-impedance study.

Gourcerol G, Benanni Y, Boueyre E, Leroi AM, Ducrotte P.

Neurogastroenterol Motil. 2013 Oct;25(10):800-e634. doi: 10.1111/nmo.12181. Epub 2013 Jul 12.

PMID:
23848571
45.

Luminal cysteine-proteases degrade colonic tight junction structure and are responsible for abdominal pain in constipation-predominant IBS.

Annaházi A, Ferrier L, Bézirard V, Lévêque M, Eutamène H, Ait-Belgnaoui A, Coëffier M, Ducrotté P, Róka R, Inczefi O, Gecse K, Rosztóczy A, Molnár T, Ringel-Kulka T, Ringel Y, Piche T, Theodorou V, Wittmann T, Bueno L.

Am J Gastroenterol. 2013 Aug;108(8):1322-31. doi: 10.1038/ajg.2013.152. Epub 2013 May 28.

PMID:
23711626
46.

Glucose-induced incretin hormone release and insulin sensitivity are impaired in patients with idiopathic gastroparesis: results from a pilot descriptive study.

Prévost G, Ducrotté P, Cailleux A, Khalfi K, Basuyau JP, Lefebvre H, Kuhn JM.

Neurogastroenterol Motil. 2013 Aug;25(8):694-9. doi: 10.1111/nmo.12150. Epub 2013 May 12.

PMID:
23663508
47.

[Application of the recommendations of the conference of consensus in front of symptoms ENT, respiratory or thoracic pains considered as due to a gastroesophageal reflux disease].

Vallot T, Ducrotte P, Bour B, Jacques JP, Houcke P, De Korwin JD, Pariente A, Aygalenq P, Coudsy B, Carrois F, Ricci L, Bruley des Varannes S.

Presse Med. 2013 May;42(5):e125-32. doi: 10.1016/j.lpm.2012.11.006. Epub 2013 Feb 13. French.

PMID:
23414966
48.

Gastric electrical stimulation decreases gastric distension-induced central nociception response through direct action on primary afferents.

Ouelaa W, Ghouzali I, Langlois L, Fetissov S, Déchelotte P, Ducrotté P, Leroi AM, Gourcerol G.

PLoS One. 2012;7(12):e47849. doi: 10.1371/journal.pone.0047849. Epub 2012 Dec 20.

49.

Gastroesophageal reflux disease: impact on work productivity and daily-life activities of daytime workers. A French cross-sectional study.

Bruley des Varannes S, Ducrotté P, Vallot T, Garofano A, Bardoulat I, Carrois F, Ricci L.

Dig Liver Dis. 2013 Mar;45(3):200-6. doi: 10.1016/j.dld.2012.11.005. Epub 2012 Dec 10.

PMID:
23238032
50.

Gastric electrical stimulation increases the discomfort threshold to gastric distension.

Gourcerol G, Ouelaa W, Huet E, Leroi AM, Ducrotte P.

Eur J Gastroenterol Hepatol. 2013 Feb;25(2):213-7. doi: 10.1097/MEG.0b013e32835a7f04.

PMID:
23075698

Supplemental Content

Loading ...
Support Center